Search filters

List of works by Georgina Arrambide

A prospective series of patients with hyperglycaemia-associated movement disorders.

scientific article published on 23 July 2011

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

scientific article published on 25 November 2020

Aggressive multiple sclerosis (1): Towards a definition of the phenotype

scientific article published on 12 June 2020

Aggressive multiple sclerosis (2): Treatment

scientific article published on 12 June 2020

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - Commentary

scientific article published on 01 November 2019

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

scientific article published on 24 October 2014

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

scientific article published in April 2017

CSF examination still has value in the diagnosis of MS - Commentary.

scientific article

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

scientific article published on 13 February 2015

Clinical impact of early brain atrophy in clinically isolated syndromes

scientific article published on 07 May 2013

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

scientific article

Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody

scientific article published on 06 February 2015

Commentary on "Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis".

scientific article

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

scientific article

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

scientific article published on 21 April 2015

Detection of central vein should be part of MS diagnostic criteria - No

scientific article published on 03 March 2020

Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.

scientific article

Early predictors of multiple sclerosis after a typical clinically isolated syndrome.

scientific article published on 19 May 2014

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

scientific article

Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease

scientific article published on 03 January 2019

Introducing the International Women in Multiple Sclerosis network

scientific article published on 01 June 2019

Lesion topographies in multiple sclerosis diagnosis: A reappraisal

scientific article published on 3 November 2017

MOG-antibody-associated disease-getting the whole picture

scientific article published on 17 October 2019

Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

scientific article published on 01 March 2019

Multiple sclerosis management during the COVID-19 pandemic

scientific article published on 10 August 2020

NMO spectrum disorders: how wide is the spectrum?

scientific article published on 01 September 2014

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

scientific article published on 01 March 2012

Neurofilament light chain level is a weak risk factor for the development of MS.

scientific article published on 12 August 2016

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus

scientific article published on 14 April 2016

Oligoclonal bands do not represent dissemination in time in the 2017 revisions to the McDonald criteria

scientific article published on 16 May 2019

Predictive markers of disease evolution after a CIS in everyday practice.

scientific article published on 20 May 2014

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

scientific article

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

scientific article published on 16 March 2015

Significant clinical worsening after natalizumab withdrawal: Predictive factors

article

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

scientific article published on 26 December 2018

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

scientific article

The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO

scientific article published on 04 August 2015

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

scientific article published on 16 February 2018

Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.

scientific article

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis

scientific article published on 21 May 2020

Value of NMO-IgG determination at the time of presentation as CIS

scientific article published on 02 May 2012

Paulina is supported by:

About Paulina

Help